on a mobile?
 
vTap
    Loading...
 
 
Video
... to prevent cervical cancer has been approved for sale in Europe. Gardasil will be given to girls as young as nine to protect them from sexually transmitted diseases which can lead to cervical ...
2 years ago
Sky News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Gardasil
Cervical cancer
Sexually transmitted disease
Go to Feed to see what's new!
share
keep
 
 
The Michigan state legislature is considering a bill that would require all 11 to 12 year old girls in the state to receive the Gardasil vaccine.
2 years ago
CBS (cbs4 - Denver)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Gardasil
Cervical cancer
Michigan State University
Go to Feed to see what's new!
share
keep
 
 
What's the truth behind exciting report? Dr. Manny separates fact from fiction
2 days ago
New York Post
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Skin cancer
What The--?!
Go to Feed to see what's new!
share
keep
 
 
Merck and Company's Gardasil is viewed by analysts as a multibillion-dollar-a-year seller. 9/2006 Reuters
2 years ago
Excite - Entertainment
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Gardasil
Go to Feed to see what's new!
share
keep
 
 
1917
New vaccine on the horizon to treat women with cervical cancer
2m 29s |
2 years ago
YouTube
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Cervical cancer
Cancer vaccine
Biotechgirl (YouTube)
Go to Feed to see what's new!
share
my users
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Sept. 22 - Merck and Company's Gardasil is viewed by analysts as a multibillion-dollar-a-year seller. Gardasil is viewed by analysts as a multibillion-dollar-a-year seller. GlaxoSmithKline Plc has a rival product called Cervarix waiting in the wings, which is slightly behind in development. Cervarix was filed for approval in Europe in March and Glaxo aims to submit it for approval in the United States before the end of the year. Katie Juhl reports.
2 years ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Gardasil
Cervarix
GlaxoSmithKline
Human papillomavirus
Merck & Co.
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use